| Name | Title | Contact Details |
|---|
Located on the majestic West Coast of British Columbia, Eversio Wellness is an expanding mushroom wellness company with big plans for the future of fungi across Canada, the US and beyond. We were founded in February 2020, right before COVID-19 became part of our vocabulary in BC – and the timing couldn`t have been more synergistic for us. Our co-founders are a family of friends with a common goal – to shape how fungi will impact the health of us and our planet. We are ordinary souls who are grateful each day for the extraordinary human experiences we`ve had in holistic nutrition, pharmaceutical sciences, mental health, marketing, business and education. We are a company that strives to be HUMANITY PLUS in every decision we make. Our intention is to offer you something you can use to upgrade your present moment and every moment of life after that! And, it all begins with a connection to the land and the mushrooms we love.
Visa Solutions Healthcare is a healthcare division that connects partners with highly qualified international registered nurses and allied clinicians. They offer a Care for your Dream program to help nurses work in the U.S. and provide diagnostics so...
Cellanyx has developed proprietary live tumor cell phenotypic biomarker tests to improve cancer risk-stratification and allow informed clinical decision making. The Companys unique approach provides quantitative and actionable information based on analysis of thousands of live tumor cells. The Companys tests employ a microfluidic platform combined with machine vision and machine learning approaches to analyze phenotypic morphological, biochemical and biophysical markers. Cellanyx has demonstrated initial clinical proof-of-concept with its lead phenotypic test in prostate cancer. The initial clinical proof-of-concept study was conducted to demonstrate improved risk stratification in men with low and intermediate Gleason grade (6 and 7) disease and reduce the number of repeat biopsies. Furthermore, analysis of field samples (away from the suspicious core) demonstrated the potential value of Cellanyx phenotypic test as it was able to analyze the tumor microenvironment conditions and predict expected adverse pathology from samples that were not taken from the suspicious core. These new findings from the Cellanyx prostate test are transformative as it will reduce the errors in diagnosing cancers early due to sampling heterogeneity of prostate biopsies.
Kluwer Health International is a Bridgewater, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Care Providers Of Minnesota is a Minneapolis, MN-based company in the Healthcare, Pharmaceuticals, & Biotech sector.